JMP Securities Reaffirms Market Outperform Rating for Addus HomeCare (NASDAQ:ADUS)

Addus HomeCare (NASDAQ:ADUS - Get Free Report)'s stock had its "market outperform" rating reissued by research analysts at JMP Securities in a report issued on Friday,Benzinga reports. They presently have a $150.00 target price on the stock. JMP Securities' price target suggests a potential upside of 30.10% from the stock's previous close.

A number of other brokerages also recently weighed in on ADUS. Stephens restated an "overweight" rating and issued a $142.00 target price on shares of Addus HomeCare in a research note on Wednesday, March 12th. Macquarie reiterated an "outperform" rating and set a $133.00 price target on shares of Addus HomeCare in a report on Tuesday, June 10th. Finally, Wall Street Zen downgraded Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. One analyst has rated the stock with a hold rating, six have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus target price of $142.57.

Addus HomeCare Stock Performance

Shares of ADUS opened at $115.30 on Friday. The firm has a market capitalization of $2.12 billion, a P/E ratio of 26.03, a P/E/G ratio of 1.63 and a beta of 0.81. Addus HomeCare has a 52 week low of $88.96 and a 52 week high of $136.72. The stock has a 50 day moving average price of $108.65 and a two-hundred day moving average price of $112.03. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.74 and a current ratio of 1.74.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its earnings results on Monday, May 5th. The company reported $1.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.23% and a net margin of 6.52%. The company had revenue of $337.71 million for the quarter, compared to analysts' expectations of $341.66 million. During the same quarter in the previous year, the firm earned $1.21 earnings per share. Addus HomeCare's quarterly revenue was up 20.3% on a year-over-year basis. Equities analysts forecast that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the company's stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total transaction of $235,175.00. Following the sale, the executive vice president now owns 7,796 shares of the company's stock, valued at approximately $896,540. This represents a 20.78% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 4.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of ADUS. Natixis raised its position in shares of Addus HomeCare by 111.9% during the 4th quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after buying an additional 132 shares in the last quarter. Smartleaf Asset Management LLC boosted its holdings in shares of Addus HomeCare by 324.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock worth $35,000 after purchasing an additional 214 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S bought a new position in shares of Addus HomeCare during the 1st quarter valued at about $41,000. Parkside Financial Bank & Trust lifted its position in Addus HomeCare by 38.6% in the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after buying an additional 148 shares during the last quarter. Finally, Meeder Asset Management Inc. purchased a new stake in Addus HomeCare in the fourth quarter worth approximately $77,000. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.